Display options
Cite
Brucker-Davis F, Panaïa-Ferrari P, Gal J, et al. Iodine Supplementation throughout Pregnancy Does Not Prevent the Drop in FT4 in the Second and Third Trimesters in Women with Normal Initial Thyroid Function. Eur Thyroid J. 2013;2(3):187-94doi: 10.1159/000350882.
Brucker-Davis, F., Panaïa-Ferrari, P., Gal, J., Fénichel, P., & Hiéronimus, S. (2013). Iodine Supplementation throughout Pregnancy Does Not Prevent the Drop in FT4 in the Second and Third Trimesters in Women with Normal Initial Thyroid Function. European thyroid journal, 2(3), 187-94. https://doi.org/10.1159/000350882
Brucker-Davis, Françoise, et al. "Iodine Supplementation throughout Pregnancy Does Not Prevent the Drop in FT4 in the Second and Third Trimesters in Women with Normal Initial Thyroid Function." European thyroid journal vol. 2,3 (2013): 187-94. doi: https://doi.org/10.1159/000350882
Brucker-Davis F, Panaïa-Ferrari P, Gal J, Fénichel P, Hiéronimus S. Iodine Supplementation throughout Pregnancy Does Not Prevent the Drop in FT4 in the Second and Third Trimesters in Women with Normal Initial Thyroid Function. Eur Thyroid J. 2013 Sep;2(3):187-94. doi: 10.1159/000350882. Epub 2013 Jul 16. PMID: 24847452; PMCID: PMC4017760.
Copy Download .nbib Format: NLM
Share it on

Eur Thyroid J. 2013 Sep;2(3):187-94. doi: 10.1159/000350882. Epub 2013 Jul 16.

Iodine Supplementation throughout Pregnancy Does Not Prevent the Drop in FT4 in the Second and Third Trimesters in Women with Normal Initial Thyroid Function.

European thyroid journal

Françoise Brucker-Davis, Patricia Panaïa-Ferrari, Jocelyn Gal, Patrick Fénichel, Sylvie Hiéronimus

Affiliations

  1. Department of Endocrinology, Diabetology and Reproductive Medicine, Nice, France ; Institut National de la Recherche Médicale, UMR U895, Université Nice-Sophia Antipolis, Nice, France.
  2. Department of Biochemistry, UMR U895, Université Nice-Sophia Antipolis, Nice, France.
  3. Department of Biostatistics, CHU de Nice, UMR U895, Université Nice-Sophia Antipolis, Nice, France.
  4. Department of Endocrinology, Diabetology and Reproductive Medicine, Nice, France.

PMID: 24847452 PMCID: PMC4017760 DOI: 10.1159/000350882

Abstract

OBJECTIVES: The aim of the study was to determine the evolution of thyroid tests throughout pregnancy and postpartum in healthy women with and without iodine supplementation.

METHODS: This was a prospective, randomized, interventional study of iodine supplementation (150 μg/day) from the first trimester until 3 months postpartum versus controls. 111 pregnant women with normal initial thyroid tests were enrolled, undergoing comprehensive thyroid assessment at each trimester. We present results of longitudinal and cross-sectional analyses.

RESULTS: Initial ioduria suggested mild iodine deficiency in both groups, while third-trimester ioduria rose to levels of iodine sufficiency in the iodine-supplemented group. In the longitudinal study, free T4 (FT4) levels decreased in the second and third trimesters compared to the first trimester in both groups, with no change in TSH, and rose postpartum, though lower than the first trimester. FT3 levels and the total T4 (TT4)/thyroxine-binding globulin (TBG) ratio followed the same evolution as FT4. TT4 levels rose due to TBG increase. Thyroglobulin (Tg) of iodine group remained stable, contrasting with the rise in the control group. In the cross-sectional study, there was no difference between the two groups in thyroid tests at any time-point, except for lower Tg in the second trimester and postpartum visits in the iodine group.

CONCLUSIONS: In healthy, mildly iodine-deficient pregnant women, a 'drop' of FT4 and TT4/TBG without TSH increase occurs between the first and second trimesters, and is not prevented by iodine supplementation, suggesting physiology. Therefore, FT4 is valuable to assess thyroid function in pregnancy in clinical practice with appropriate trimester-specific reference range. It brings up reflection on threshold for diagnosis and treatment of hypothyroxinemia.

Keywords: Free T4; Iodine; Ioduria; Pregnancy; Thyroglobulin

References

  1. Ann Endocrinol (Paris). 2009 Sep;70(4):218-24 - PubMed
  2. J Clin Endocrinol Metab. 2008 Jul;93(7):2616-21 - PubMed
  3. Postgrad Med J. 2001 Apr;77(906):217-20 - PubMed
  4. J Clin Endocrinol Metab. 1995 Jan;80(1):258-69 - PubMed
  5. J Clin Endocrinol Metab. 2012 Aug;97(8):2543-65 - PubMed
  6. Clin Endocrinol (Oxf). 2003 Sep;59(3):282-8 - PubMed
  7. Am J Obstet Gynecol. 1991 Feb;164(2):482-5 - PubMed
  8. Eur J Endocrinol. 2002 Jul;147(1):29-34 - PubMed
  9. J Clin Endocrinol Metab. 2010 Sep;95(9):4227-34 - PubMed
  10. N Engl J Med. 2012 Feb 9;366(6):493-501 - PubMed
  11. J Clin Endocrinol Metab. 2000 Sep;85(9):3191-8 - PubMed
  12. Paediatr Perinat Epidemiol. 2012 Jul;26 Suppl 1:108-17 - PubMed
  13. Am J Obstet Gynecol. 2010 Feb;202(2):e6; author reply e6 - PubMed
  14. Clin Chim Acta. 2010 Sep 6;411(17-18):1348-53 - PubMed
  15. J Clin Endocrinol Metab. 2009 Sep;94(9):3188-90 - PubMed
  16. Endocr Rev. 1997 Jun;18(3):404-33 - PubMed
  17. Public Health Nutr. 2007 Dec;10(12A):1606-11 - PubMed
  18. Eur Thyroid J. 2013 Jan;1(4):264-73 - PubMed
  19. Thyroid. 2011 Oct;21(10):1081-125 - PubMed
  20. Thyroid. 2004 Dec;14(12):1084-90 - PubMed
  21. Eur J Endocrinol. 1996 Apr;134(4):443-8 - PubMed
  22. Endocr Rev. 2009 Jun;30(4):376-408 - PubMed
  23. Thyroid. 2011 May;21(5):541-6 - PubMed
  24. Clin Chem. 1989 Sep;35(9):1891-6 - PubMed
  25. J Clin Endocrinol Metab. 2009 Sep;94(9):3234-41 - PubMed
  26. Am J Obstet Gynecol. 2009 Mar;200(3):260.e1-6 - PubMed
  27. J Clin Endocrinol Metab. 2000 Nov;85(11):3975-87 - PubMed
  28. J Clin Endocrinol Metab. 2008 May;93(5):1737-42 - PubMed
  29. Br J Nutr. 2013 Sep 14;110(5):831-9 - PubMed
  30. J Clin Endocrinol Metab. 1993 Oct;77(4):1078-83 - PubMed

Publication Types